Plain-English translation of NCT06112418 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Diabetes Mellitus, Type 2 research guide โThis study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
This trial is testing whether using advanced heart imaging to directly visualize coronary artery disease โ rather than relying solely on risk factors like age and cholesterol โ helps prevent heart attacks and other cardiovascular events in people with type 2 diabetes, prediabetes, or metabolic syndrome. Half of participants will receive usual care guided by traditional risk factors, while the other half will receive personalized care based on their imaging results and managed by a remote cardiology team.
Despite widespread treatment of traditional risk factors like high cholesterol and high blood pressure, heart disease remains the leading cause of death. The current approach treats many people with risk factors who never develop heart disease, while missing others who have significant heart disease despite few risk factors. This trial tests whether direct imaging can better identify who truly needs treatment and what treatments work best for each person.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
All participants will have a heart imaging scan called a coronary CT angiogram (CCTA) to look for heart disease. Those in the imaging-guided group will receive personalized treatment recommendations and education from a remote cardiology team based on their scan results, with ongoing communication via phone, tablet, or computer. The other group will receive standard care from their usual doctors. Both groups will be followed over time to see which approach better prevents heart problems.
AI-generated summary from trial data ยท Jun 1, 2026 ยท Not medical advice
United States